1. AB0028 Activated stromal cells induce ccl20 release and t cell migration. (12th June 2018) Authors: Cafaro, G.; Garcia-Melchor, E.; Akbar, M.; Gilchrist, D.S.; Kitson, S.M.; Siebert, S.; Millar, N.L.; McInnes, I.B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0068 Alarmins s100a8 and s100a9 modulate the inflammatory microenvironment in early tendinopathy. (12th June 2018) Authors: Crowe, L.A.N.; Akbar, M.; Patommel, K.; Kitson, S.M.; Garcia Melchor, E.; Gilchrist, D.S.; Murrell, G.A.; McInnes, I.B.; Millar, N.L. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0074 The Effect of Extracellular Vesicles on Human in Vitro Osteoclastogenesis in Health and in Arthritis. (15th July 2016) Authors: Marton, N.; Kovacs, O.T.; Baricza, E.; Gyori, D.; Mocsai, A.; Meier, F.; Goodyear, C.S.; McInnes, I.B.; Buzas, E.I.; Nagy, G.S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 922 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0095 IL-21R signature in synovial tissue and blood of patients with rheumatoid arthritis. (23rd January 2014) Authors: Frleta, M.; King, V.; Reilly, J.H.; Kerr, S.; Gilchrist, D.S.; Tornehave, D.; Neisig, A.; Lundsgaard, D.; Miller, A.M.; McInnes, I.B. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0244 MIR-155 Expression in B Cells of Rheumatoid Arthritis Patients Is Related To Follicular Synovitis and Mirrors B Cell Subpopulations Changes after IL-6R Inhibitor Treatment. (15th July 2016) Authors: Alivernini, S.; Tolusso, B.; Petricca, L.; Kurowska-Stolarska, M.; Fedele, A.L.; Gremese, E.; Di Sante, G.; McInnes, I.B.; Ferraccioli, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0451 NI-0101, a Monoclonal Antibody Targeting Toll Like Receptor 4 (TLR4) Being Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine. (9th June 2015) Authors: Monnet, E.; Shang, L.; Lapeyre, G.; deGraaf, K.; Hatterer, E.; Buatois, V.; Elson, G.; Ferlin, W.; Gabay, C.; Sokolove, J.; Jones, S.A.; Choy, E.H.; McInnes, I.B.; Kosco-Vilbois, M.; de Min, C. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity. (17th July 2019) Authors: Bain, K.A.; McDonald, E.; Moffat, F.; Tutino, M.; Castelino, M.; Barton, A.; Cavanagh, J.; Ijaz, U.Z.; Siebert, S.; McInnes, I.B.; Astrand, A.; Holmes, S.; Milling, S.W.F. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity. (1st January 2020) Authors: Bain, K.A.; McDonald, E.; Moffat, F.; Tutino, M.; Castelino, M.; Barton, A.; Cavanagh, J.; Ijaz, U.Z.; Siebert, S.; McInnes, I.B.; Astrand, A.; Holmes, S.; Milling, S.W.F. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. C-terminal citrullinated peptide alters antigen-specific APC:T cell interactions leading to breach of immune tolerance. Issue 135 (February 2023) Authors: Malcolm, J.; Nyirenda, M.H.; Brown, J.L.; Adrados-Planell, A.; Campbell, L.; Butcher, J.P.; Glass, D.G.; Piela, K.; Goodyear, C.S.; Wright, A.J.; McInnes, I.B.; Millington, O.R.; Culshaw, S. Journal: Journal of autoimmunity Issue: Issue 135(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind head‐to‐head monotherapy study. (14th July 2021) Authors: Gottlieb, A.B.; Merola, J.F.; Reich, K.; Behrens, F.; Nash, P.; Griffiths, C.E.M.; Bao, W.; Pellet, P.; Pricop, L.; McInnes, I.B. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗